Literature DB >> 17157240

Phacomorphic glaucoma: case and review.

Joseph Sowka1.   

Abstract

Phacomorphic glaucoma is a lens-induced secondary angle closure glaucoma that may occur as a result of mature cataract formation. A patient with markedly asymmetric cataract and anterior chamber depth was referred after the development of significant eye pain and elevated intraocular pressure that did not respond to topical antiglaucoma medications. The presence of an asymmetric mature lens, angle closure, and intraocular pressure elevation in the affected eye led to the diagnosis of phacomorphic glaucoma. Because the patient was systemically ill, physically frail, and had poor vision in the affected eye since birth, secondary to strabismic amblyopia, initial therapy was medically directed toward pain management. Cycloplegia, corticosteroids, and aqueous suppressants successfully ameliorated the patient's intraocular pressure and adequately controlled pain. However, progression to phacolysis and subsequent failure of pain management necessitated referral for lens extraction. The diagnosis and mechanism of phacomorphic glaucoma is discussed along with a review of current treatment modalities.

Entities:  

Mesh:

Year:  2006        PMID: 17157240     DOI: 10.1016/j.optm.2006.08.013

Source DB:  PubMed          Journal:  Optometry        ISSN: 1558-1527


  3 in total

1.  Prospective case series on trabecular-iris angle status after an acute episode of phacomorphic angle closure.

Authors:  Jacky Lee; Jimmy Lai; Doris Yick; Can Yuen
Journal:  Int J Ophthalmol       Date:  2013-02-18       Impact factor: 1.779

2.  Lens-induced glaucoma in a tertiary centre in northeast of Malaysia.

Authors:  A Yaakub; N Abdullah; I Siti Raihan; L S Ahmad Tajudin
Journal:  Malays Fam Physician       Date:  2014-08-31

3.  Functional results of cataract surgery in the treatment of phacomorphic glaucoma.

Authors:  Andreea Moraru; Gabriela Pînzaru; Anca Moţoc; Dănuţ Costin
Journal:  Rom J Ophthalmol       Date:  2017 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.